Literature DB >> 2142982

The prevalence of Huntington's disease in Tasmania.

S A Pridmore1.   

Abstract

This is the first field study to determine the prevalence of Huntington's disease in Tasmania. It is based on almost complete enumeration of affected individuals as of January 1, 1990. The prevalence was found to be 12.1 per 100,000, which is somewhat below the figure often attributed to Tasmania but about twice that of the accepted average in Occidental populations.

Entities:  

Mesh：

Year:  1990        PMID： 2142982     DOI： 10.5694/j.1326-5377.1990.tb136828.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


  6 in total

Review 1.  Huntington's disease: the coming of age.

Authors:  Mritunjay Pandey; Usha Rajamma
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

2.  Long-term monitoring of the mortality trend of Huntington's disease in Austria.

Authors:  Eva Ekestern; Gustav Lebhart
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 3.  The epidemiology of Huntington's disease.

Authors:  P S Harper
Journal:  Hum Genet       Date:  1992-06       Impact factor: 4.132

4.  The epidemiology of Huntington's disease in Northern Ireland.

Authors:  P J Morrison; W P Johnston; N C Nevin
Journal:  J Med Genet       Date:  1995-07       Impact factor: 6.318

Review 5.  3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington's disease: past, present and future.

Authors:  Isaac Túnez; Inmaculada Tasset; Verónica Pérez-De La Cruz; Abel Santamaría
Journal:  Molecules       Date:  2010-02-10       Impact factor: 4.411

6.  Huntington's disease among immigrant groups and Swedish-born individuals: a cohort study of all adults 18 years of age and older in Sweden.

Authors:  Per Wändell; Sten Fredrikson; Axel C Carlsson; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  Neurol Sci       Date:  2021-01-30       Impact factor: 3.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.